Nanocomposite material capable of adjusting synaptic plasticity and preparation method thereof
By introducing polyamino acids with glutamate receptor inhibitors into nanocomposites, the inadequate targeting and biocompatibility of synaptic regulation in the prior art is solved, and effective relief of chronic oral pain is achieved.
CN119684613APending Publication Date: 2025-03-25SOUTHERN MEDICAL UNIV STOMATOLOGICAL HOSPITAL (GUANGDONG STOMATOLOGICAL HOSPITAL GUANGDONG DENTAL DISEASE PREVENTION & TREATMENT GUIDANCE CENT)
0 Cites 0 Cited by
Patent Information
- Application Number
- CN202411877762.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-19
- Publication Date
- 2025-03-25
AI Technical Summary
Technical Problem
The prior art has problems with insufficient targeting and biocompatibility in regulating synaptic plasticity and relieving chronic oral pain.
Method used
By forming copolymers with polylactic acid and polyamic acids, nanocomposites are prepared, and polyamic acids are grafted and modified, and side chain groups with glutamate receptor inhibitors are added to accurately interfere with synaptic transition sensitization and control the abnormal manifestations of long-term synaptic enhancement in the central nervous system.
Benefits of technology
Accurate regulation of synapses is achieved, which weakens the excessive propagation of pain signals and relieves chronic oral pain.
✦ Generated by Eureka AI based on patent content.
Abstract
The invention discloses a nano composite material capable of adjusting synaptic plasticity and a preparation method thereof, and belongs to the technical field of nano materials. Polylactic acid and polyamino acid form a copolymer, the nano composite material is formed, the polyamino acid is subjected to graft modification, and a glutamic acid receptor inhibitor passes through the polyamino acid terminal, so that the synaptic plasticity can be adjusted. By regulating and controlling the synapses, the transient sensitization of the synapses is accurately intervened, and the abnormal expression of long-term enhancement of the synapses of the central nervous system is controlled, so that the chronic oral pain is relieved.
Need to check novelty before this filing date? Find Prior Art